# Albumin and Crystalloid Administration in Septic Shock

> **NCT05148286** · PHASE4 · RECRUITING · sponsor: **Asan Medical Center** · enrollment: 2426 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Treatment
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05148286
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-17
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 2426 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05148286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05148286, "Albumin and Crystalloid Administration in Septic Shock". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05148286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*